About Ali Farahanchi
Form D filings for SURGE Therapeutics in 2023 list Ali Farahanchi as director.
Ali Farahanchi first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ali Farahanchi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ali Farahanchi works with at each company, as listed on that company's latest Form D.
SURGE Therapeutics, Inc. · Form D, Jun 2, 2023
GG
Gary Goldberg
Director
MG
Michael Goldberg
President and Chief Executive Officer, director
JC
Jason Coloma
Director
CC
Chuck Carignan
Executive officer
AG
Antonio Gualberto
Executive officer
KH
Kouki Harasaki
Director